A study found that typical cholesterol exams could be missing an important indicator of heart disease risk in certain people.
Lerodalcibep is an adnectin-based, small protein-binding, third generation proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor.
Using hormone replacement therapy (HRT) to reduce cardiovascular risk during menopause remains a topic of debate. The ...
Atherosclerotic cardiovascular disease is a major health concern worldwide and requires effective preventive measures. Lp(a) (lipoprotein [a]) has recently garnered attention as an independent risk ...
She corrects the widespread misconception, claiming that eradicating fat to reduce cholesterol is "nonsense." Contrary to ...
ApoB is emerging as a crucial piece of the heart health puzzle, even as sophisticated machines whir and beep with promises of ...
High levels of variability in cholesterol over time were linked to a significantly higher risk for dementia and cognitive ...
Understand what the results of your cholesterol test mean and find out what might be causing your high cholesterol.
The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...
The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of cardiovascular events, according to results from an analysis by a Mount Sinai ...
The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...